Shigenori Goto 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（10 件）

• [2025] Clinical Evaluation of Immune Cell Therapy in Esophageal Cancer Resistant to Immunochemotherapy
  DOI: https://doi.org/10.21873/anticanres.17716
• [2025] [A Case of Remarkable Immune-Cell Therapy Efficacy in a Patient with Renal Pelvic Cancer Refractory to Immune Checkpoint Inhibitors and Chemotherapy].
• [2024] A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer
  DOI: https://doi.org/10.3892/ol.2024.14234
• [2023] Effects of adoptive T‐cell immunotherapy on immune cell profiles and prognosis of patients with unresectable or recurrent cholangiocarcinoma
  DOI: https://doi.org/10.1002/ijc.34716
• [2023] Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG)
  DOI: https://doi.org/10.1016/j.jcyt.2023.06.007
• [2022] Prospective study of adoptive activated αβT lymphocyte immunotherapy for refractory cancers: development and validation of a response scoring system
  DOI: https://doi.org/10.1016/j.jcyt.2022.09.007
• [2022] Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid Tumors
  DOI: https://doi.org/10.21873/anticanres.15918
• [2021] Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy
  DOI: https://doi.org/10.21873/anticanres.15216
• [2021] Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
  DOI: https://doi.org/10.1186/s13256-020-02634-z
• [2021] Long-term, 25-year Survival Following Surgery and Immune Cell Therapy Combined with Chemotherapy for HER2-Positive Metastatic Breast Cancer
  DOI: https://doi.org/10.31488/bjcr.167

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。